GPCR
Structure Therapeutics Inc. American Depositary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.87B
P/E Ratio
—
EPS
$-2.54
Beta
-1.25
52W High
$94.90
52W Low
$14.42
50-Day MA
$65.04
200-Day MA
$41.95
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Structure Therapeutics Inc. American Depositary Shares
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-185.13M |
| Operating Margin | 0.00% |
| Return on Equity | -11.90% |
| Return on Assets | -9.39% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $21.41 |
| Price-to-Book | 2.50 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -13.46 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $70.84M |
| Float | $164.53M |
| % Insiders | 3.08% |
| % Institutions | 95.73% |
Analyst Ratings
Consensus ($109.00 target)
4
Strong Buy11
Buy1
HoldData last updated: 4/8/2026